A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2
暂无分享,去创建一个
B. Lee | Su-Jin Park | C. Chae | I. Kang | T. Oh | K. Park | Siyeon Yang | H. Ham | Guang-Ri Jin | J. Jeong
[1] Su-Jin Park,et al. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions. , 2018, Veterinary microbiology.
[2] E. Eveno,et al. Maternally-derived antibodies (MDAs) impair piglets' humoral and cellular immune responses to vaccination against porcine reproductive and respiratory syndrome (PRRS). , 2016, Veterinary microbiology.
[3] Su-Jin Park,et al. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs , 2015, Clinical and Vaccine Immunology.
[4] C. Chae,et al. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge. , 2014, Veterinary microbiology.
[5] C. Chae,et al. Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation , 2014, Veterinary Research.
[6] C. Chae,et al. Comparison of the virulence of European and North American genotypes of porcine reproductive and respiratory syndrome virus in experimentally infected pigs. , 2013, Veterinary journal.
[7] M. Murtaugh,et al. Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). , 2011, Vaccine.
[8] T. Kimman,et al. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. , 2009, Vaccine.
[9] F. Osorio,et al. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. , 2007, Veterinary microbiology.
[10] M. Murtaugh,et al. Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus , 1995, Archives of Virology.
[11] F. Osorio,et al. Role of neutralizing antibodies in PRRSV protective immunity. , 2004, Veterinary immunology and immunopathology.
[12] M. Torremorell,et al. Detection of U.S., Lelystad, and European-Like Porcine Reproductive and Respiratory Syndrome Viruses and Relative Quantitation in Boar Semen and Serum Samples by Real-Time PCR , 2004, Journal of Clinical Microbiology.
[13] R. Rowland,et al. A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b. , 2001, Virology.
[14] C. Gagnon,et al. Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates , 2000, Archives of Virology.
[15] M. Murtaugh,et al. Porcine Reproductive and Respiratory Syndrome Virus Comparison: Divergent Evolution on Two Continents , 1999, Journal of Virology.
[16] E. Snijder,et al. The molecular biology of arteriviruses. , 1998, The Journal of general virology.
[17] P. Halbur,et al. Comparison of the Pathogenicity of Two US Porcine Reproductive and Respiratory Syndrome Virus Isolates with that of the Lelystad Virus , 1995, Veterinary pathology.